Amedisys Inc. (AMED)

133.80
2.20 1.70
NASDAQ : Health Services
Prev Close 131.62
Open 132.49
Day Low/High 132.40 / 134.15
52 Wk Low/High 97.38 / 141.97
Volume 162.89K
Avg Volume 327.20K
Exchange NASDAQ
Shares Outstanding 32.17M
Market Cap 4.28B
EPS 3.60
P/E Ratio 35.16
Div & Yield N.A. (N.A)

Latest News

Amedisys And ClearCare Forge Partnership To Coordinate Home Health Care And Personal Care

Amedisys And ClearCare Forge Partnership To Coordinate Home Health Care And Personal Care

BATON ROUGE, La., July 25, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc.

Amedisys Announces Second Quarter Earnings Release And Conference Call Date

Amedisys Announces Second Quarter Earnings Release And Conference Call Date

BATON ROUGE, La., July 19, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc.

See How Amedisys, Inc. Ranks Among Analysts' Top Picks With Strong Buyback Activity

See How Amedisys, Inc. Ranks Among Analysts' Top Picks With Strong Buyback Activity

A study of analyst recommendations at the major brokerages shows that Amedisys, Inc. is the #70 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity.

Analyst Favorites With Strong Buyback Activity: Amedisys Ranks As A Top Pick

Analyst Favorites With Strong Buyback Activity: Amedisys Ranks As A Top Pick

A study of analyst recommendations at the major brokerages shows that Amedisys, Inc. is the #74 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity.

First Week Of January 2019 Options Trading For Amedisys (AMED)

First Week Of January 2019 Options Trading For Amedisys (AMED)

Investors in Amedisys, Inc. saw new options become available this week, for the January 2019 expiration.

Noteworthy Tuesday Option Activity: AMED, CWH, FOSL

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Amedisys, Inc. , where a total volume of 1,602 contracts has been traded thus far today, a contract volume which is representative of approximately 160,200 underlying shares (given that every 1 contract represents 100 underlying shares).

Amedisys: Quantitative Buy and Strong Charts

Amedisys: Quantitative Buy and Strong Charts

Buyers have been increasingly aggressive.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMED, BCOV, CLS, DWSN, EDR, EQC, IFF, ONDK, PAGP, PKE, PTR, SJI, SRE, SWM, TRMB, TWIN Downgrades: ANDE, CBT, COLL, FLEX, GPK, GSM, HI, NAP, NTLA, RGS, UONE, UONEK Initiations: ELVT, SNDR Read on to get TheStreet Quant Ratings' detailed report:

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AOI, ATSG, CKH, CRM, DDS, EQBK, FSTR, GNK, NEWM, OAS, RDC, RRC, TCMD, UHS, WTW Downgrades: AHGP, AMED, AXE, CTRE, CULP, DOC, EMKR, GLW, HABT, IT, KBR, RP, SGEN, SPOK, SWM, TACO, UGP, UTHR Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Amedisys Reports Fourth Quarter And Year End 2017 Financial Results

Amedisys Reports Fourth Quarter And Year End 2017 Financial Results

Issues 2018 Guidance

Watch: Former Humana Executive Supports the CVS-Aetna Deal

Watch: Former Humana Executive Supports the CVS-Aetna Deal

Paul Kusserow, CEO of home health care provider Amedysis and a former Humana executive, thinks CVS Health's agreement to buy Aetna, announced on Monday, is "very exciting."

Short Interest Moves 12% Lower For AMED

Short Interest Moves 12% Lower For AMED

The most recent short interest data has been released for the 11/15/2017 settlement date, which shows a 350,029 share decrease in total short interest for Amedisys, Inc. , to 2,541,688, a decrease of 12.10% since 10/31/2017.

AMED Crosses Above Average Analyst Target

AMED Crosses Above Average Analyst Target

In recent trading, shares of Amedisys, Inc. have crossed above the average analyst 12-month target price of $57.25, changing hands for $58.49/share.

2017 HomeCare Elite Recognizes Top Amedisys Care Centers Nationwide

2017 HomeCare Elite Recognizes Top Amedisys Care Centers Nationwide

158 Amedisys Home Health Care Centers Recognized

TheStreet Quant Rating: A- (Buy)